New York, September 21 (FinanceEnquiry.com) – Analysts at Jefferies & Company downgrade their rating on the shares of Questcor Pharmaceuticals, Inc (NASDAQ: QCOR) from BUY to HOLD. The 12-month target price has been reduced from $60 to $30.
In a research note published on September 20, the analysts mention that after the proclaimed decision of Aetna Inc (NYSE: AET) on September 19, rating on Questcor Pharmaceuticals was lowered. Furthermore, regarding the possible reimbursement for Acthar, some confusion is believed existing at present and it is due to the unclear statements that were issued in the Clinical Policy Bulletin of Aetna (Buy, $39.43) on the topic of Acthar.
Nonetheless, it was confirmed that except for infantile spasm, Aetna is not compensating for Acthar after having conversation with a representative of Aetna on September 19. In addition, as Questcor Pharmaceuticals would need data from a clinical trial published in a peer-reviewed medical journal, due to this, it has been learned that there is just small space for QCOR to reverse this policy decision.
Thus, a reversal of decision, in the near-term, is improbable as together with the discussions with neurologists, the reimbursement change was decided after analysis of clinical data by directors of pharmacy. Finally, it is just unusual for claims to effectively navigate this process, despite the fact that patients may submit an appeal on a case-by-case basis, the analysts add further.
New York, May 24 (FinanceEnquiry.com) – In view of the fact that tremendous instability in the Nikkei kept investors on edge, the yen bounced back largely and Asian stocks dropped to one-month lows on May...Sony Xperia ZR: Truly Marveling - May 23, 2013
New York, May 24 (FinanceEnquiry.com) – Marvelous is perhaps the only word to describe majesty of upcoming Sony Xperia ZR that is supposed to enter the market in the current quarter. This Micro-SIM...T-Mobile myTouch 2: Tap to Feel Comprised Specifications - May 23, 2013
Furthermore, if to believe...Spice Mi-500 Stellar Horizon: Enhancing Prospect of using Technology - May 22, 2013
New York, May 21 (FinanceEnquiry.com) – In accordance with official Government statistics, home costs soared 0.4pc in March. Detailing it, as mentioned by the Office of National Statistics (ONS), increasing from...ZTE Grand X2 In: Name Defines Splendor - May 21, 2013
New York, May 21 (FinanceEnquiry.com) – Proclamation regarding the release of ZTE Grand X2 In has recently been made in May only and the gadget is supposed to hit the industry in third quarter of the...Asian Shares Soar; the Yen Inches Higher - May 20, 2013
New York, May 20 (FinanceEnquiry.com) – At the same time as Asian shares soared in response to US equities rallying on positive economic statistics, the yen inched up on the very first day of the week as soon as...Applications for Jobless Benefits Soared 32,000 Earlier Week - May 17, 2013
New York, May 17 (FinanceEnquiry.com) – The number of Americans looking for jobless benefits soared by 32,000 previous week to a cyclically adjusted 360,000, being the maximum since late March. The jump...WTI Crude Falls since Fuel Requirement Slumps with Economic Fragility - May 16, 2013